银华中证创新药产业ETF发起式联接A(012781)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
277,495.48 |
711,147.90 |
- |
56,928.41 |
| 存出保证金 |
138,594.22 |
423,969.22 |
473,555.28 |
54,097.05 |
| 交易性金融资产 |
497,959,247.62 |
406,911,141.24 |
191,875,697.45 |
213,471,100.44 |
| 其中:股票投资 |
- |
- |
- |
- |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
3,133,559.16 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
10,791,274.49 |
6,145,561.38 |
3,032,303.03 |
2,219,061.43 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
547,636,950.12 |
446,201,881.15 |
211,527,291.66 |
278,809,639.00 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
72,554.23 |
1,035,678.41 |
46,241,498.78 |
| 应付赎回款 |
20,873,019.10 |
10,793,838.49 |
6,992,770.38 |
5,654,902.53 |
| 应付管理人报酬 |
11,626.69 |
11,125.53 |
4,930.16 |
4,832.46 |
| 应付托管费 |
1,162.66 |
1,112.55 |
493.02 |
483.23 |
| 应付销售服务费 |
29,251.32 |
29,207.73 |
11,736.37 |
9,325.83 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
2,916.20 |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
87,366.50 |
161,635.59 |
75,152.32 |
150,100.77 |
| 负债合计 |
21,002,426.27 |
11,072,390.32 |
8,120,760.66 |
52,061,143.60 |
| 所有者权益 |
| 实收基金 |
791,815,899.56 |
632,964,797.18 |
310,552,838.75 |
391,690,259.80 |
| 未分配利润 |
-265,181,375.71 |
-197,835,306.35 |
-107,146,307.75 |
-164,941,764.40 |
| 所有者权益合计 |
526,634,523.85 |
435,129,490.83 |
203,406,531.00 |
226,748,495.40 |
| 负债及所有者权益总计 |
547,636,950.12 |
446,201,881.15 |
211,527,291.66 |
278,809,639.00 |